Covered recipient · General Payments record
NIKKI MARLENE MOORE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$488.90
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $167.10 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $32.20 | 2 |
| Otsuka America Pharmaceutical, Inc. | $29.64 | 1 |
| ABBVIE INC. | $26.17 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $26.11 | 1 |
| Lilly USA, LLC | $20.60 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $16.77 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.17 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107687422 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.10 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123303994 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.10 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123304330 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.61 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086299686 | CMS |
| Boston Scientific Corporation | $16.77 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092430623 | CMS |
| Lilly USA, LLC | $20.60 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135897724 | CMS |
| Novartis Pharmaceuticals Corporation | $26.11 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087146048 | CMS |
| Otsuka America Pharmaceutical, Inc. | $29.64 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119142793 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.